Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 5,333 | 2,534 | 2,534 | 2,549 | 2,562 |
| Cost of Goods | 7,799 | N/A | N/A | N/A | N/A |
| Gross Profit | -2,466 | 2,534 | 2,534 | 2,549 | 2,562 |
| Operating Expenses | 54,314 | 48,936 | 48,936 | 43,478 | 33,046 |
| Operating Income | -55,981 | -46,402 | -46,402 | -40,929 | -30,484 |
| Other Income | 2 | -1,026 | -1,026 | -2,472 | -233 |
| Pre-tax Income | -55,979 | -47,428 | -47,428 | -43,401 | -30,717 |
| Net Income Continuous | -55,979 | -47,428 | -47,428 | -43,401 | -30,717 |
| Net Income | $-55,979 | $-47,428 | $-47,428 | $-43,401 | $-30,717 |
| EPS Basic Total Ops | -0.33 | -0.28 | -0.28 | -0.31 | -1.33 |
| EPS Basic Continuous Ops | -0.33 | -0.28 | -0.28 | -0.31 | -1.33 |
| EPS Diluted Total Ops | -0.33 | -0.28 | -0.28 | -0.31 | -1.33 |
| EPS Diluted Continuous Ops | -0.33 | -0.28 | -0.28 | -0.31 | -1.33 |
| EBITDA(a) | $-53,214 | $-44,166 | $-43,966 | $-38,598 | $-29,082 |